help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-1904
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
91/5/1961    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dyntar, D.
Right arrow Articles by Donath, M. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dyntar, D.
Right arrow Articles by Donath, M. Y.
Related Collections
Right arrow Cardiovascular Endocrinology
Right arrow Diabetes and Insulin
The Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 5 1961-1967
Copyright © 2006 by The Endocrine Society

High Glucose Alters Cardiomyocyte Contacts and Inhibits Myofibrillar Formation

Daniela Dyntar, Pavel Sergeev, Jelena Klisic, Patrice Ambühl, Marcus C. Schaub and Marc Y. Donath

Divisions of Endocrinology and Diabetes (D.D., M.Y.D.) and Nephrology (J.K., P.A.), University Hospital, CH-8091 Zurich, Switzerland; and Institute of Pharmacology and Toxicology (P.S., M.C.S.), University of Zurich, CH-8032 Zurich, Switzerland

Address all correspondence and requests for reprints to: Marc Y. Donath, M.D., Division of Endocrinology and Diabetes, University Hospital of Zurich, Rämistrasse 100, CH-8091 Zurich, Switzerland. E-mail: marc.donath{at}usz.ch.

Context: The frequency of diabetes-related heart failure along with the prevalence of diabetes is increasing. Diabetic cardiomyopathy is considered to be a distinct disease in the absence of discernible coronary artery and other defined heart disease. Previously we have shown that glucose and palmitic acid induce degeneration of myofibrils and modulate apoptosis in cultivated cardiomyocytes.

Objective: Here we studied the mechanisms of diabetic cardiomyopathy in more detail.

Results: Streptozotocin-induced diabetes led to a significant increase in cardiac cell apoptosis. Furthermore, cardiomyocyte contacts were reduced. In vitro, prolonged exposure of cultured adult cardiomyocytes to high glucose concentrations drastically reduced myofibrillar formation. In particular, sarcomeric myosin heavy chains and cardiac {alpha}-actin were reduced, whereas the nonsarcomeric smooth muscle {alpha}-actin remained unaffected. The deleterious effects of glucose on myofibril formation were prevented by antioxidative regimens.

Conclusions: Thus, a diabetic milieu leads to multiple structural alterations of the heart including apoptosis, loss of intercellular contacts, and malformation of contractile structures.




This article has been cited by other articles:


Home page
J EndocrinolHome page
Z. Li, T. Zhang, H. Dai, G. Liu, H. Wang, Y. Sun, Y. Zhang, and Z. Ge
Endoplasmic reticulum stress is involved in myocardial apoptosis of streptozocin-induced diabetic rats
J. Endocrinol., March 1, 2008; 196(3): 565 - 572.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society